Search

In Multiple Sclerosis (MS), new brain lesions appear because of inflammation and loss of myelin (the structure covering nerves). Project Overview In Multiple Sclerosis (MS), new brain lesions appear because of inflammation and loss of myelin (the structure covering nerves). MS treatments stop...

RATIONALE: There are no effective disease modifying therapies for amyotrophic lateral sclerosis (ALS). Project Overview RATIONALE: There are no effective disease modifying therapies for amyotrophic lateral sclerosis (ALS). Complete understanding of the physiopathology of ALS is lacking, and...

The loss of connections between nerve cells is an early indicator of Alzheimer’s disease. Project Overview The loss of connections between nerve cells is an early indicator of Alzheimer’s disease. The loss of these connections also causes difficulty thinking and processing information....

Our ability to learn is directly proportional to our ability to detect the difference between a prediction and its outcome. Project Overview Our ability to learn is directly proportional to our ability to detect the difference between a prediction and its outcome. Reinforcement learning theories,...

Meet the junior researchers behind the 2022 ALS Canada – Brain Canada Trainee Awards. Dr. Hussein Ghazale is the recipient of a $165,000 ALS Canada – Brain Canada 2022 Trainee Award. Meet the junior researchers behind the 2022 ALS Canada – Brain Canada Trainee Awards Dr. Hussein Ghazale is the...

Brain Canada and Heart & Stroke are pleased to officially launch the Heart-Brain Connection IMPACT Award, a multi-disciplinary, multi-institutional, integrative research competition that will investigate the complex interactions between the heart and the brain by leveraging the power of...

Brain Canada and JDRF are pleased to officially launch the JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants, a program to support research on the development, validation, or implementation of interventions that address mental health concerns in people with type 1...

Source: The Neuro An innovative new program based at The Neuro has received $2.6 million from Brain Canada and CQDM. Led by neuroscientist Thomas Durcan, PhD, in collaboration with scientists from Merck pharmaceutical company, the project will dissect the role of microglia in degenerative...

A Canadian research team, based in Montreal and Halifax, is using sophisticated stem cell technology to uncover the causes of bipolar disorder, develop new ways to screen for it, determine who will respond to treatment, and begin to identify new drug therapies. Brain Canada/Bell Let’s Talk study...

Early detection critical to early interventions and improved outcomes, U of A researchers say. By Gillian Rutherford Read the full article here.